News Diagnostics & Imaging Breast Cancer Decision-Making Support

NCCN Guidelines Update Recommends Breast Cancer Screening at Age 35 for High-Risk Women Identified by AI

April 15, 2026 By ASCO AI Staff 2 min read
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter
Objective:

To update breast cancer screening guidelines for high-risk women based on AI-driven risk assessment, emphasizing the need for personalized approaches.

Key Findings:
  • AI-driven risk prediction models outperform traditional methods in estimating breast cancer risk, which is crucial for clinical decision-making.
  • Image-based AI models have a median AUC of 0.72, while traditional models like Gail and Tyrer-Cuzick have an AUC of 0.61, indicating a significant improvement.
  • Models combining imaging and clinical risk factors achieve a median AUC of 0.73, further enhancing risk assessment accuracy.
Interpretation:

The incorporation of AI in risk assessment allows for earlier and more personalized breast cancer screening strategies, potentially improving outcomes for high-risk women, provided that access to these tools is equitable.

Limitations:
  • The guidelines may not address all demographic variations in breast cancer risk, which could limit their effectiveness across diverse populations.
  • Access to advanced AI tools may vary across different healthcare settings, impacting the implementation of these guidelines.
Conclusion:

The updated guidelines represent a significant shift towards personalized breast cancer screening, enhancing the identification of women at increased risk.

ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.

KOL Commentary
Watch

Related Content